Literature DB >> 6401256

Platelet dynamics in chronic liver disease using the 111Indium oxine label.

P J Toghill, S Green.   

Abstract

Platelet dynamics in chronic liver disease have been studied using 111Indium-8-hydroxyquinolone (111In-oxine) as a platelet label. In 20 patients, mainly with alcoholic cirrhosis, the platelet mean life span was reduced in 12 and the splenic platelet pool increased, often markedly so, in 15. However, the platelet count was not significantly related to mean bile span, the splenic platelet pool, or spleen size. Whereas splenic platelet pool size is related to spleen size in most of the haematological 'big-spleen' syndromes, this did not apply to those patients with chronic liver disease. Technically, 111In-oxine is a more appropriate platelet label than 51Cr in ill and thrombocytopenic patients with liver disease.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6401256      PMCID: PMC1419926          DOI: 10.1136/gut.24.1.49

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  14 in total

1.  A six-channel automated platelet aggregometer.

Authors:  J Adams; S Heptinstall; J R Mitchell
Journal:  Thromb Diath Haemorrh       Date:  1975-12-15

2.  (51Cr)platelet kinetics in thrombocytopenia. Correlation between splenic sequestration of platelets and response to splenectomy.

Authors:  C A Ries; D C Price
Journal:  Ann Intern Med       Date:  1974-06       Impact factor: 25.391

3.  The exchangeable splenic platelet pool studied with epinephrine infusion in idiopathic thrombocytopenic purpura and in patients with splenomegaly.

Authors:  I Branehög; A Weinfeld; B Roos
Journal:  Br J Haematol       Date:  1973-08       Impact factor: 6.998

4.  The effect of chromium on platelet function in vitro.

Authors:  H E Kattlove; T H Spaet
Journal:  Blood       Date:  1970-05       Impact factor: 22.113

5.  Radionuclide distribution following injection of 111Indium-labelled platelets.

Authors:  I Klonizakis; A M Peters; M L Fitzpatrick; M J Kensett; S M Lewis; J P Lavender
Journal:  Br J Haematol       Date:  1980-12       Impact factor: 6.998

6.  Use of indium-111/oxine to label human platelets.

Authors:  R J Hawker; L M Hawker; A R Wilkinson
Journal:  Lancet       Date:  1978-08-26       Impact factor: 79.321

7.  Indium (111In)-labelled human platelets: optimal method.

Authors:  R J Hawker; L M Hawker; A R Wilkinson
Journal:  Clin Sci (Lond)       Date:  1980-03       Impact factor: 6.124

8.  Evaluation of indium-111 as a new high photon yield gamma-emitting "physiological" platelet label.

Authors:  U Scheffel; P A McIntyre; B Evatt; J A Dvornicky; T K Natarajan; D R Bolling; E A Murphy
Journal:  Johns Hopkins Med J       Date:  1977-06

9.  Kinetics, distribution and sites of destruction of 111indium-labelled human platelets.

Authors:  A D Heyns; M G Lötter; P N Badenhorst; O R van Reenen; H Pieters; P C Minnaar; F P Retief
Journal:  Br J Haematol       Date:  1980-02       Impact factor: 6.998

10.  Platelet dynamics in chronic liver disease with special reference to the role of the spleen.

Authors:  P J Toghill; S Green; F Ferguson
Journal:  J Clin Pathol       Date:  1977-04       Impact factor: 3.411

View more
  6 in total

Review 1.  Haemostatic problems in liver disease.

Authors:  D A Kelly; E G Tuddenham
Journal:  Gut       Date:  1986-03       Impact factor: 23.059

2.  Mechanism of thrombocytopenia in liver cirrhosis: kinetics of indium-111 tropolone labelled platelets.

Authors:  Y Aoki; K Hirai; K Tanikawa
Journal:  Eur J Nucl Med       Date:  1993-02

3.  The Effect of Transjugular Intrahepatic Portosystemic Shunt on Platelet Counts in Patients With Liver Cirrhosis.

Authors:  Omar I Massoud; Nizar N Zein
Journal:  Gastroenterol Hepatol (N Y)       Date:  2017-05

4.  Mechanisms of thrombocytopenia induced by interferon therapy for chronic hepatitis B.

Authors:  M Sata; Y Yano; Y Yoshiyama; T Ide; R Kumashiro; H Suzuki; K Tanikawa
Journal:  J Gastroenterol       Date:  1997-04       Impact factor: 7.527

5.  Course of thrombocytopenia of chronic liver disease after transjugular intrahepatic portosystemic shunts (TIPS). A retrospective analysis.

Authors:  S P Lawrence; D C Lezotte; J D Durham; D A Kumpe; G T Everson; B M Bilir
Journal:  Dig Dis Sci       Date:  1995-07       Impact factor: 3.199

6.  Platelet IgG antibodies are significantly increased in chronic liver disease.

Authors:  Dimitrios Christodoulou; Konstantinos Katsanos; Eleftheria Zervou; Vasileios Theopistos; Athanasios Papathanasopoulos; Leonidas Christou; Epameinondas V Tsianos
Journal:  Ann Gastroenterol       Date:  2011
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.